Company Filing History:
Years Active: 2019-2023
Title: The Innovative Contributions of Matthew S. Curtis
Introduction
Matthew S. Curtis is a prominent inventor based in Pasadena, California. He has made significant contributions to the field of molecular analysis, holding a total of five patents. His work focuses on advancing methods for single-cell analysis and drug susceptibility testing.
Latest Patents
Among his latest patents is a groundbreaking method for performing single-cell analysis of molecules and molecular complexes. This patent describes methods, systems, and related compositions that enable single-cell marking of nucleic acids and proteins in a sample. The techniques involve in-cell or in-organelle barcoding of nucleic acid and protein complexes, allowing for the identification of specific markers at the single-cell or organelle level. Another notable patent involves microfluidic measurements that assess the response of microorganisms to drug treatments. This innovation provides rapid methods and devices to determine whether a microorganism in a sample is susceptible or resistant to a particular treatment.
Career Highlights
Matthew has worked with esteemed organizations such as the California Institute of Technology and Talis Biomedical Corporation. His experience in these institutions has allowed him to develop and refine his innovative approaches to molecular analysis.
Collaborations
Throughout his career, Matthew has collaborated with notable colleagues, including Rustem F. Ismagilov and Eugenia Khorosheva. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Matthew S. Curtis exemplifies the spirit of innovation in the field of molecular analysis. His contributions through patents and collaborations have the potential to significantly impact scientific research and medical treatments.